In conclusion, the VISTA-mediated immune inhibitory pathway in tumour cells regulates protective antitumour immunity, and blocking of VISTA in tumour cells may provide a promising immunotherapeutic strategy for improving the antitumour response. The gene discussed is VSIR; the disease is neoplasm.